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OBJECTIVES This study examined whether dietary intake or plasma levels of antioxidant vitamins were
independently associated with common carotid artery intima-media (wall) thickness (IMT)
or focal plaque, or both, in a large, randomly selected community population.
BACKGROUND Oxidation of low-density lipoprotein (LDL) cholesterol is thought to be important in early
atherogenesis. Antioxidant micronutrients may therefore protect against lipid peroxidation
and atherosclerotic vascular disease.
METHODS We studied 1,111 subjects (558 men and 553 women; age 52 13 years [mean SD], range
27 to 77). We measured dietary vitamin intake and fasting plasma levels of vitamins A, C and
E, lycopene and alpha- and beta-carotene and performed bilateral carotid artery B-mode
ultrasound imaging.
RESULTS After adjustment for age and conventional risk factors, there was a progressive decrease in
mean IMT, with increasing quartiles of dietary vitamin E intake in men (p  0.02) and a
nonsignificant trend in women (p  0.10). Dietary vitamin E levels accounted for 1% of the
variance in measured IMT in men. For plasma antioxidant vitamins, there was an inverse
association between carotid artery mean IMT and plasma lycopene in women (p  0.047),
but not in men. None of the other dietary or plasma antioxidant vitamins, nor antioxidant
vitamin supplements, were associated with carotid artery IMT or focal carotid artery plaque.
CONCLUSIONS This study provides limited support for the hypothesis that increased dietary intake of vitamin
E and increased plasma lycopene may decrease the risk of atherosclerosis. No benefit was
demonstrated for supplemental antioxidant vitamin use. (J Am Coll Cardiol 2001;38:
1788–94) © 2001 by the American College of Cardiology
Oxidation of low-density lipoprotein (LDL) is thought to
be important in the development of early atherosclerosis (1).
Oxidized LDL possesses a number of biologic properties
that may promote atherogenesis (2), and agents that protect
against lipid peroxidation may therefore reduce the devel-
opment of atherosclerotic vascular disease. In animal stud-
ies, the administration of antioxidants has been shown to
inhibit lipid oxidation and reduce the development of
atherosclerosis (3,4). However, a large number of epidemi-
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ologic studies investigating a relationship between antioxi-
dant vitamins and vascular disease have yielded results that
conflict with the results of randomized clinical trials (5).
There is limited human data regarding the effect of antiox-
idant intake on measures of atherosclerosis. High-resolution
carotid artery B-mode ultrasound imaging has been used
previously to assess the relationship between dietary and
plasma antioxidants and early atherosclerosis; however,
there were inconsistent correlations in the Atherosclerosis
Risk In Communities (ARIC) study in the U.S. (6,7) and
the Etude sur le Viellissement Arte´riel (EVA) in France (8).
To further evaluate the contribution of dietary and
plasma antioxidant vitamins to atherosclerotic vascular dis-
ease, we used high-resolution carotid artery B-mode ultra-
sound imaging to determine whether dietary intake or
plasma levels of vitamins A, C and E, beta- and alpha-
carotene and lycopene were independently associated with
carotid artery intima-media thickness (IMT) and focal
plaque in a large, randomly selected cross-sectional Austra-
lian population with a broad age range and an equal number
of men and women.
METHODS
Subjects. Subjects were participants in the Perth Carotid
Ultrasound Disease Assessment Study (CUDAS). The
techniques used in this study have been previously reported
(9). This was a random, electoral-roll survey (10) of 1,111
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subjects from Perth, Western Australia, with equal numbers
of men and women and equal numbers of subjects in each
decile of age between 27 and 77 years examined between
June 1995 and December 1996 (61% of those eligible agreed
to participate). Because of the potential for alterations in
reported dietary intake and supplemental vitamin use in
subjects with a history of symptomatic vascular disease (n 
87), analyses were restricted to the 1,024 asymptomatic
subjects. Written, informed consent was obtained from all
study participants. The study protocol was approved by the
Institutional Ethics Committee of the University of West-
ern Australia.
Laboratory measurements. In all subjects, a fasting venous
blood sample was obtained. The standard procedure was to
separate plasma by centrifugation shortly after venipuncture
and to transport samples in ice-cooled containers protected
from direct light to the laboratory. Plasma levels of antiox-
idant vitamins (vitamins A, C and E, alpha- and beta-
carotene and lycopene) and homocysteine were determined
by reverse-phase, high-performance liquid chromatography.
The interassay coefficient of variation was 6% for vitamin A,
10% for lycopene and the carotenoids, 6% for vitamin C and
5% for vitamin E in our laboratory. Total cholesterol,
high-density lipoprotein (HDL) cholesterol and triglyceride
levels were determined enzymatically on a Hitachi 747
autoanalyzer (Tokyo, Japan). The LDL cholesterol was
calculated by Friedewald’s method (11).
Risk factor assessment. A self-administered questionnaire
similar to that used by the 1994 Australian National Heart
Foundation Perth Risk Factor Prevalence Survey was used
to record a history of hypertension, hyperlipidemia, diabe-
tes, angina pectoris, myocardial infarction and stroke (12).
Diet assessment. All subjects completed a semi-quantitative
food-frequency questionnaire prepared by the Australian
Commonwealth Scientific and Industrial Research Organi-
zation (CSIRO), Division of Human Nutrition, Adelaide,
South Australia. This questionnaire was self-administered,
but all responses were reviewed by a research nurse on the
day of their visit. The average daily intakes of vitamins A, C
and E and beta-carotene were derived from the dietary
questionnaire, using the QUESTAN program of the
CSIRO Dietary Assessment by Computer Program, a
previously validated program for estimating vitamin intake
from food-frequency data (13). The average daily vitamin
intake was derived from dietary estimates and adjusted for
supplemental vitamin use.
Carotid artery ultrasound examination. Bilateral carotid
artery B-mode ultrasound imaging was performed according
to a standardized protocol, as previously described (9). A
thorough search of the full length of the distal common
carotid artery, carotid artery bulb and internal and external
carotid arteries was made to determine the presence of focal
plaque. Plaque was defined as a clearly identified area of
increased focal thickness (1 mm) of the intima-media
layer.
The IMT was defined as the distance between the
characteristic echoes from the lumen–intima and media–
adventitia interfaces (14). Three end-diastolic images were
digitized and analyzed from the right and left distal com-
mon carotid arteries in each subject, by use of semi-
automated edge-detection software (15). The mean IMT
measurement for a given subject was the average of these six
measurements. Repeat measurement of randomly selected
scans revealed no significant variation in the mean IMT
measurement obtained during any specific period of the
study. The intraobserver coefficient of variability for image
acquisition and analysis in our laboratory was 2.9% for
sonographer no. 1 and 4.8% for sonographer no. 2. The
interobserver coefficient of variability was 5.9%. The mean
(SD) difference in carotid artery IMT between repeat
measurements varied from 0.03  0.02 mm for intraob-
server variability to 0.05  0.04 mm for interobserver
variability.
Statistical analysis. Dietary vitamin intakes were adjusted
for total energy (kilojoule) intake, with the nutrient density
and total energy intake included in multivariate models (16).
The fat-soluble plasma vitamins were found to be correlated
with plasma lipid fractions and were adjusted for plasma
total cholesterol as well as triglycerides for all analyses (17).
Subjects were classified into gender-specific quartiles ac-
cording to their dietary intake or plasma antioxidant vitamin
concentrations. Logarithmic transformation was used for
continuous variables, with skewed distributions where ap-
propriate. Carotid artery mean IMT was treated as a
continuous variable, and subjects were also categorized as
those with or without focal carotid artery plaque. Analysis of
variance was used to relate quartiles of dietary or plasma
antioxidant vitamins with mean IMT, and if overall signif-
icance was demonstrated, intergroup differences were as-
sessed by multiple comparisons testing and the t test for
linear trends. Logistic regression was used to test the
independent relationship between dietary or plasma antiox-
idant vitamins (independent variables) and focal plaque
(dependent variable). The risk of focal plaque for each
vitamin quartile, compared with the risk for the lowest
quartile, was estimated and expressed as the odds ratio
(OR), derived as the anti-logarithm of the logistic regres-
sion coefficients. All analyses were adjusted for age, LDL
Abbreviations and Acronyms
ARIC  Atherosclerosis Risk In Communities study
CI  confidence interval
CSIRO  Commonwealth Scientific and Industrial
Research Organization
CUDAS  Carotid Ultrasound Disease Assessment
Study
EVA  Etude sur le Viellissement Arte´riel
IMT  intima-media thickness
HDL  high-density lipoprotein
LDL  low-density lipoprotein
OR  odds ratio
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cholesterol, smoking, diabetes, systolic blood pressure, ho-
mocysteine and family history. The models were fitted
separately for men and women. Statistical significance
was taken as a two-sided p value 0.05 (without adjust-
ment for multiple comparisons). Results are expressed as
the mean value  SD or OR with 95% confidence
interval (CI), unless otherwise stated. Analysis was per-
formed with SAS statistical software (SAS Institute,
Cary, North Carolina).
RESULTS
Subjects. The clinical characteristics of the study popula-
tion (n  1,111; 558 men and 553 women; mean age 52 
13 years) are shown in Table 1. There was a similar number
of men and women in each age decade from 27 to 77 years.
A similar prevalence of conventional vascular risk factors
was observed for men and women, except that men were
more likely to have higher systolic and diastolic blood
pressure, lower HDL cholesterol and higher triglyceride
levels, compared with women (Table 1). A previous history
of myocardial infarction or stroke was recorded in 8% (n 
87) of the total population.
Dietary and supplement antioxidant intake and plasma
antioxidant levels. Table 2 demonstrates the average di-
etary intake of vitamins for subjects initially unadjusted and
then adjusted for vitamin supplement use. Women were
more likely to consume antioxidant-containing vitamin
supplements, compared with men. There were no differ-
ences in supplement use across age deciles or in subgroups
defined by a history of smoking, diabetes, hypertension or
hyperlipidemia. However, subjects with a history of clinical
vascular disease had higher reported use of vitamin supple-
ments, compared with asymptomatic subjects (27% vs. 12%;
p  0.001 by the chi-square test). Women reported an
average 17% lower dietary energy intake, compared with
men (p  0.0001). Independent of kilojoule intake, women
had a lower reported intake of vitamin A, but higher intakes
of beta-carotene and vitamin C, with no difference in
vitamin E intake. After adjustment for energy intake,
women had higher proportional intakes of beta-carotene




(n  553) Significance
Age (yr) 52 13 53 13
Systolic BP (mm Hg) 130 17 127 20 *
Diastolic BP (mm Hg) 82 9 79 11 *
Hypertension 24% 24%
Total cholesterol (mmol/l) 5.5 1.0 5.6 1.0
LDL cholesterol (mmol/l) 3.7 0.9 3.6 0.9
HDL cholesterol (mmol/l) 1.2 0.3 1.5 0.4 *
Triglycerides (mmol/l) 1.5 0.8 1.1 0.6 *
Hyperlipidemia 27% 22%
Current smoker 17% 13%
Obese (BMI 30) 17% 16%
Diabetes 2% 2%
Family history IHD 17% 17%
Myocardial infarction 6% 2% *
Stroke 2% 2%
*p  0.05 for difference between men and women. The paired t test was used for
continuous variables and the chi-square test for proportions. Data are presented as the
mean value  SD or percentage of patients.
BMI body mass index; BP blood pressure; HDL high-density lipoprotein;
IHD  ischemic heart disease; LDL  low-density lipoprotein.
Table 2. Dietary and Supplement Intake and Plasma Levels of Antioxidant Vitamins
Men (n  558) Women (n  553)
DifferenceMean  SD Median Mean  SD Median
Dietary antioxidant vitamins
Vitamin A intake (IU/day) 798  1,036 416 608  657 375 *
Supplement adjusted† 848  1,076 416 651  727 382 *
Beta-carotene intake (IU/day) 5,642  3,442 5058 6,189  3,090 5709 *
Supplement adjusted 5,785  3,640 5136 6,359  3,332 5810 *
Vitamin C intake (mg/day) 138  79 127 152  80 138 *
Supplement adjusted 183  175 138 216  190 152 *
Vitamin E intake (mg/day) 14.4  17.7 9.5 13.0  14.0 9.4
Supplement adjusted 23.7  47.4 10.4 22.7  44.7 10.7
Plasma antioxidant vitamins
Vitamin A (mol/l) 2.87  0.64 2.8 2.51  0.68 2.4 *
Alpha-carotene (mol/l) 0.17  0.24 0.1 0.21  0.16 0.2 *
Beta-carotene (mol/l) 0.61  0.57 0.5 0.90  0.76 0.7 *
Vitamin C (mg/l) 2.63  1.50 2.6 3.39  1.87 3.4 *
Vitamin E (mol/l) 39.1  13.1 37 38.7  11.5 37
Lycopene (mol/l) 0.39  0.26 0.3 0.41  0.25 0.4
Antioxidant vitamin supplement use
Multivitamin supplements 11% 16% *
Vitamin A supplements 5% 7%
Beta-carotene supplements 4% 5%
Vitamin C supplements 15% 20% *
Vitamin E supplements 10% 18% *
*p  0.05 for difference, between men and women. The paired t test was used for continuous variables and the chi-square test test for proportions. †Dietary vitamin intakes
adjusted to include vitamin supplement use.
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and vitamins C and E (p  0.05), with no difference in
vitamin A intake between women and men.
The average plasma antioxidant vitamin levels are shown
in Table 2. Women had lower plasma vitamin A levels,
compared with men, but they had higher alpha- and
beta-carotene and vitamin C levels. Plasma vitamin E and
lycopene levels were similar between men and women.
Plasma antioxidant levels correlated with dietary intake for
vitamin C (Spearman rho correlation coefficient [rs] 0.34,
p  0.001), vitamin E (rs  0.34, p  0.001) and
beta-carotene (rs  0.30, p  0.001), but not for vitamin A
(rs  0.03, p  0.34). No differences in the relationship
between dietary and plasma levels were seen between men
and women or in subgroups defined by a history of smoking,
diabetes, hypertension, hyperlipidemia or clinical vascular
disease.
Dietary and plasma antioxidants and carotid artery ath-
erosclerosis. In the overall population, the average carotid
artery mean IMT was 0.71 0.14 mm, and 26% of subjects
had focal plaque identified. Men had increased mean IMT
values (0.73  0.15 vs. 0.69  0.13 mm; p  0.001) and a
higher prevalence of focal plaque (29% vs. 22%, p  0.001
by the chi-square test), compared with women. Mean IMT
was significantly associated with conventional vascular risk
factors, including age, male gender, systolic blood pressure,
LDL cholesterol, pack-years of smoking, plasma homocys-
teine and diabetes.
Table 3 shows the relationship between dietary vitamins
and carotid artery IMT, after adjustment for age, gender,
total energy intake and conventional risk factors. There was
a progressive decrease in mean IMT with increasing quar-
tiles of dietary vitamin E intake in men (test for linear
trends, p  0.02) and a nonsignificant trend in women (test
for linear trends, p  0.10). In men, multiple regression
analysis showed that dietary vitamin E was an independent
predictor of mean IMT (partial R2  0.01, p  0.006 for
addition to the model), with the entire model accounting for
50% of the variability in mean IMT (model R2  0.51,
p  0.0001). There was no association between use of any
of the antioxidant vitamin supplements and mean IMT.
Table 4 shows the relationship between plasma antioxi-
dant vitamins and carotid artery IMT. There was an inverse
association between carotid artery mean IMT and plasma
levels of lycopene in women (test for linear trends, p 
0.047), but not in men.
The prevalence of carotid artery plaque decreased with
increasing quartiles of dietary vitamin E (p  0.03) in
women, with no significant associations between plaque and
dietary antioxidant vitamins in men. The prevalence of
carotid artery plaque decreased with increasing plasma levels
of alpha-carotene (p  0.03) and lycopene (p  0.001),
with a nonsignificant trend for vitamin A (p  0.06) in
women and with increasing quartiles of vitamin A (test for
trends, p  0.02) and lycopene (p  0.001) in men. When
adjusted for age, hypertension, LDL cholesterol, smoking,
homocysteine, diabetes, waist-to-hip ratio and total energy
intake, logistic regression analysis found no residual associ-
ation between any dietary or plasma antioxidant vitamins or
supplemental vitamin use and the risk of focal plaque in
men or women.
DISCUSSION
In this study, supplemental antioxidant vitamin use was not
associated with mean IMT or carotid artery plaque. No
independent association was seen for any of the dietary or
plasma antioxidant vitamins with focal plaque. Dietary
intake of vitamin E in men and plasma lycopene levels in
women were found to be inversely associated with mean
common carotid artery IMT, independent of conventional
risk factors; however, it is not clear whether the different
associations seen in women versus men were biologically
significant or due to statistical chance. The finding of an
effect in men may be due to the fact that men have a thicker
IMT and therefore a higher chance of showing an effect, but
this would not explain the association with plasma levels of
lycopene seen in women. The most likely interpretation is
that these weak associations are consistent with the gener-
ally weak association of antioxidant vitamins with markers
of atherosclerosis.
Biologic plausibility versus clinical trial results. There
are well-documented biologic mechanisms to anticipate a
protective effect of antioxidant vitamins on atherosclerosis.
Oxidative modification of LDL cholesterol confers a range
Table 3. Adjusted* Mean IMT According to Gender-Specific





1 0.702  0.011 0.682  0.009
2 0.705  0.011 0.675  0.009
3 0.709  0.011 0.675  0.009
4 0.701  0.011 0.680  0.009
t test for linear trends p  0.99 p  0.90
Beta–carotene
1 0.700  0.011 0.674  0.009
2 0.693  0.011 0.691  0.009
3 0.706  0.011 0.681  0.008
4 0.722  0.012 0.667  0.009
t test for linear trends p  0.12 p  0.45
Vitamin C
1 0.697  0.011 0.681  0.009
2 0.711  0.011 0.684  0.009
3 0.692  0.011 0.677  0.008
4 0.716  0.012 0.673  0.009
t test for linear trends p  0.44 p  0.39
Vitamin E
1 0.706  0.011 0.686  0.009
2 0.727  0.011 0.684  0.009
3 0.708  0.011 0.676  0.008
4 0.678  0.011 0.669  0.009
t test for linear trends p  0.02 p  0.10
*In the intima-media thickness (IMT) comparisons, the factors adjusted for were age,
systolic blood pressure, low density lipoprotein cholesterol, smoking, homocysteine,
diabetes, family history and total energy intake. Data are presented as the mean
value  SEM.
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of biologic properties that may enhance its role in early
atherogenesis (18). Agents that protect LDL from oxidation
have been shown in a range of in vitro and animal models to
reduce the development and progression of atherosclerosis
(19). Among these, the antioxidant micronutrients, includ-
ing the carotenoids and vitamins C and E, have gained wide
interest because of the potential for prevention of athero-
sclerotic vascular disease in humans. Despite this, random-
ized, controlled trials of antioxidant vitamins in cardiovas-
cular disease have thus far yielded largely negative results
(20). The most recent study of 9,000 participants at high
risk of cardiovascular disease followed for 4.5 years showed
no benefit of supplemental vitamin E on death or cardio-
vascular events (21). These studies have not specifically
addressed the effects of antioxidant vitamins on the initia-
tion and early progression of atherosclerosis (5).
Antioxidant vitamins and carotid artery IMT. Subclini-
cal atherosclerosis can be accurately assessed in large-
population studies by B-mode ultrasound measurement of
the carotid artery wall (22–24). Carotid artery IMT corre-
lates strongly with the presence of focal carotid artery plaque
and conventional risk factors (23,24). The presence of
carotid artery IMT and focal carotid artery plaque has also
been found to predict the risk of future vascular events
(25–27). Previous information on the relationship between
antioxidant vitamins and early carotid artery atherosclerosis
has come from only two ultrasound studies, with inconsis-
tent results. In the ARIC study, dietary intake of antioxi-
dant vitamins was assessed in 6,318 women and 4,989 men
with asymptomatic coronary heart disease (6). They found
that carotid artery IMT was inversely related to dietary
vitamin C intake in men and women (test for trends across
quintiles of intake, p  0.035 and p  0.019, respectively)
and inversely related to alpha-tocopherol intake in women
(p  0.033), but only in subjects 55 years old. In a
subsequent case-control comparison from the ARIC group,
231 patients (60% men) with increased carotid artery IMT
(90th percentile of IMT for the entire cohort) were
compared with 231 matched control subjects (75th per-
centile of IMT), with regard to their serum antioxidant
vitamin levels, among other factors (7). They observed that
patients had lower serum levels of the carotenoids beta-
cryptoxanthin (p  0.02 by the t test) and lutein plus
zeaxanthin (p 0.05) than control subjects, but, contrary to
the hypothesis, patients also had nonsignificantly higher
alpha-tocopherol and retinol levels than control subjects.
This follow-up study was further confounded by the delay
of three years between the carotid artery examination and
the collection of the serum antioxidants.
The EVA study examined the associations of plasma
carotenoids, selenium, erythrocyte vitamin E and a marker
of lipid peroxidation by ultrasound measurement of carotid
artery atherosclerosis in an elderly cohort (aged 59 to 71
years) of 476 men and 711 women from France (8). They
observed an independent inverse association between eryth-
rocyte vitamin E and common carotid artery IMT in men
(test for linear trends across quartiles of vitamin E, p 
0.041) and women (p  0.045), but no independent
association of carotid artery IMT and carotid artery plaque
with plasma carotenoids.
In the present study, we also found only weak correlations
between antioxidant vitamin intake and carotid artery ath-
erosclerosis. Dietary vitamin E intake was independently
and inversely associated with mean IMT in men (test for
linear trends, p  0.02), with a nonsignificant trend in
women. The effect of vitamin E intake was modest, adding
1% to the variance in measured IMT in men. Among
plasma vitamins, only the naturally derived carotenoid
lycopene was inversely associated with mean IMT in
women. We found no independent association between
vitamin supplements and IMT or between any dietary or
plasma antioxidant vitamins and the risk of carotid artery
Table 4. Adjusted* Mean IMT According to Gender-Specific






1 0.704  0.012 0.679  0.009
2 0.726  0.011 0.676  0.009
3 0.696  0.011 0.673  0.009
4 0.694  0.011 0.686  0.009
t test for linear trends p  0.27 p  0.63
Alpha-carotene
1 0.691  0.013 0.688  0.010
2 0.714  0.011 0.677  0.009
3 0.719  0.011 0.670  0.009
4 0.693  0.011 0.679  0.009
t test for linear trends p  0.84 p  0.38
Beta-carotene
1 0.701  0.012 0.680  0.009
2 0.706  0.011 0.677  0.009
3 0.712  0.010 0.673  0.009
4 0.695  0.011 0.682  0.009
t test for linear trends p  0.77 p  0.97
Lycopene
1 0.711  0.013 0.688  0.009
2 0.712  0.012 0.686  0.009
3 0.701  0.012 0.669  0.009
4 0.695  0.012 0.668  0.009
t test for linear trends p  0.22 p  0.047
Vitamin C
1 0.708  0.011 0.677  0.009
2 0.707  0.011 0.678  0.009
3 0.703  0.011 0.677  0.009
4 0.699  0.011 0.681  0.009
t test for linear trends p  0.47 p  0.80
Vitamin E
1 0.718  0.011 0.687  0.009
2 0.693  0.011 0.667  0.009
3 0.706  0.011 0.670  0.009
4 0.699  0.011 0.687  0.009
t test for linear trends p  0.30 p  0.91
*In the intima-media thickness (IMT) comparisons, the factors adjusted for were age,
systolic blood pressure, low density lipoprotein cholesterol, smoking, homocysteine,
diabetes, family history and total energy intake. Data are presented as the mean
value  SEM.
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plaque. Taken in context with the previous studies, our
results suggest that any association between individual
antioxidant vitamins and early atherosclerosis is likely to be
modest and variable according to gender and the population
studied. The modest and variable effects of individual
antioxidant vitamins seen in these studies could conceivably
be a chance finding, due to the large number of variables
studied.
Significance of the findings of this study. This was a
cross-sectional study of an atherosclerotic surrogate, but it
represents a large number of subjects with an equal gender
ratio and a broad age range, with equal numbers in each age
decile. The subjects were participants in a random survey of
the electoral roll and are likely to reflect the general
Australian population. The exclusion of subjects with evi-
dent cardiovascular disease should reduce the potential bias
of recent changes in diet, because of the occurrence of
disease. The negative results are consistent with the findings
of the carotid artery substudy of a trial of vitamin E
supplementation, which also showed a lack of effect of
vitamin E supplementation on the rate of progression of
carotid artery atherosclerosis (28).
Although food-frequency questionnaires provide only an
approximate measure of usual dietary intake, there was a
moderate correlation between plasma vitamin levels and
dietary intakes, comparable to correlations found in previous
reports (29). Assessment of both measures should allow
stratification of subjects within the group, with regard to
their vitamin status. The common food sources of several
antioxidant vitamins (especially fruits and vegetables) raise
the possibility that it is a combination of vitamins that may
provide benefit. Some trials (21,30) showing a lack of
benefit with vitamin E supplementation may have over-
looked an effect of the combination or even pro-oxidant
effects of vitamin E given in isolation (31).
Conclusions. This study provides limited support for the
hypothesis that higher dietary consumption of vitamin E
may reduce the development of early atherosclerosis. We
found no protective effect from the use of antioxidant-
containing vitamin supplements on carotid artery athero-
sclerosis. Further studies are required to assess the role of
antioxidant vitamin combinations and other potential anti-
atherogenic aspects of diet.
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